DNA, oligosaccharides, and mononucleotides stimulate oligomerization of human lactoferrin

Journal of Molecular Recognition

Volumn 22, Issue 4, 2009, Pages 330-342

  Nevinskii, Alexander G ^a   Soboleva, Svetlana E ^a   Tuzikov, Fedor V ^b   Buneva, Valentina N ^a   Nevinsky, Georgy A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b BORESKOV INSTITUTE OF CATALYSIS   (Russian Federation)

Author keywords

Atp; Dna; Human lactoferrin; Influence on rate and degree of oligomerization

Indexed keywords

DNA; LACTOFERRIN; LIGAND; NUCLEOTIDE; OLIGOSACCHARIDE;

ARTICLE; CHEMISTRY; DRUG EFFECT; GEL CHROMATOGRAPHY; HUMAN; KINETICS; LASER; PROTEIN QUATERNARY STRUCTURE; SMALL ANGLE SCATTERING; SOLUTION AND SOLUBILITY; TIME; TITRIMETRY; X RAY DIFFRACTION;

CHROMATOGRAPHY, GEL; DNA; HUMANS; KINETICS; LACTOFERRIN; LASERS; LIGANDS; NUCLEOTIDES; OLIGOSACCHARIDES; PROTEIN STRUCTURE, QUATERNARY; SCATTERING, SMALL ANGLE; SOLUTIONS; TIME FACTORS; TITRIMETRY; X-RAY DIFFRACTION;

EID: 67650267000     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.952     Document Type: Article

References (38)

1. Amouric M., Marvaldi J., Pichon J., Bellot F., Figarella C. 1984. Effect of lactoferrin on the growth of a human colon adenocarcinoma cell line-comparison with transferrin. In Vitro 20: 543-548.
2. Anderson B., Baker H., Norris G., Rice D., Baker E. 1989. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 å resolution. J. Mol. Biol. 209: 711-734.
3. Babina S., Nevinsky G. 2004. Lactoferrin interacts with nucleotides. Nucleosides Nucleotides Nucleic Acids 23: 1043-1046.
4. Babina S., Semenov D., Buneva V., Nevinsky G. 2005. Human milk lactoferrin hydrolyzes nucleoside-5' -triphosphates. Mol. Biol. (Mosk.) 39: 513-520.
5. Babina S., Tuzikov F., Tuzikova N., Buneva V., Nevinsky G. 2006. The effect of nucleotides on oligomeric state of human lactoferrin. Mol. Biol. (Mosk.) 40: 137-150.
6. Bagby G., Bennet R. 1982. Feedback regulation of granulopoiesis: polymerization of lactoferrin abrogates its ability to inhibit CSA production. Blood 60: 108-112.
7. Bennett R., Merrit M., Gabor G. 1986. Lactoferrin binds to neutrophilic membrane DNA. Br. J. Haematol. 63: 105-117.
8. Birgens H. 1985. Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia. Scand. J. Haematol. 34: 326-331.
9. De Sousa M., Breedvelt F., Dynesius-Trentham R., Trentham D., Lum J. 1988. Iron, iron-binding proteins and immune system cells. Ann. N. Y. Acad. Sci. 526: 310-322.
10. Fersht A. 1977. Enzyme Structure and Mechanism. W. H. Freeman and Co.: San Francisco.
11. Fleet J. 1995. A new role for lactoferrin: DNA binding and transcription activation. Nutr. Rev. 53: 226-227.
12. Furmanski P., Li Z., Fortuna M., Swamy C., Das M. 1989. Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity J. Exp. Med. 170: 415-429.
13. Gahr M., Speer C., Damerau B., Sawatzki G. 1991. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J. Leukoc. Biol. 49: 427-433.
14. Gill P., Wright M., Murray W. 1981. Practical Optimization. Elsevier Science, Amsterdam.
15. He J., Furmanski P. 1999. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373: 721-724.
16. Kanyshkova T., Semenov D., Buneva V., Nevinsky G. 1999. Human milk lactoferrin binds two DNA molecules with different affinities. FEBS Lett. 451: 235-237.
17. Kanyshkova T., Babina S., Semenov D., Isaeva N., Vlassov A., Neustroev K., Kul'minskaya A., Buneva V., Nevinsky G. 2003. Multiple enzymic activities of human milk lactoferrin. Eur. J. Biochem. 270: 3353-3361.
18. Levay P., Viljoen M. 1995. Lactoferrin: a general review. Haematologica 80: 252-267.
19. Mann D., Romm E., Migliorini M. 1994. Deleniation of the glycosaminoglycan binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269: 23661-23667.
20. Mantel C., Miyazawa K., Broxmeyer H. 1994. Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity. Adv. Exp. Med. Biol. 357: 121-132.
21. Mazurier J., Spik G. 1980. Comparative study of the iron-building properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629: 399-408.
22. Nevinsky G., Babina S. 2003. Human milk lactoferrin and its polyfunctional biological functions. In Protein Structures. Kaleidoscope of Structural Properties and Functions, Uversky V (ed.). Research Signpost: India; 499-530.
23. Nilsson MR, Dobson CM. 2003. In vitro characterization of lactoferrin aggregation and amyloid formation. Biochemistry 42: 375-382.
24. Petrov AK, Kozlov AS, Taraban MB, Goryachkovskaya TN, Malyshkin SB, Popik SB, Peltek SE. 2005. Soft ablation of biological objects caused by free-electron laser submillimeter radiation. Dokl. Biochem. Biophys. 404: 357-359.
25. Sawatzki G., Rich I. 1989. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15: 371-385.
26. Semenov D., Kanyshkova T., Buneva V., Nevinsky G. 1999. Human milk lactoferrin binds ATP and dissociates into monomers. Biochem. Mol. Biol. Int. 47: 177-184.
27. Shelpakova IR, Zaksas NP, Komissarova LN, Kovalevskij SV. 2002. Spectral methods for analysis of high-purity gallium with excitation of spectra in the two-jet arc plasmatron. J. Anal. At. Spectrom. 17: 270-273.
28. Sousa M., Brock J. 1989. Iron in Immunity: Cancer and Inflammation. John Wiley&Sons: New York.
29. Svergun D., Feigin L. 1986. X-ray and Neutron Small-Angle Scattering. Nauka: Moscow.
30. Tuzikov F., TuzikovaN, Galimov R., Panin L., Nevinsky G. 2002. General model to describe the structure and dynamic balance between different human serum lipoproteins and its practical application. Med. Sci. Monit. 8: MT79-88.
31. Tuzikov F., Zinoviev V., Malygin E., Ankilova V., Moor N., Lavrik O. 1988a. Application of the small-angle X-ray scattering techinique for the study of equilibrium enzyme-substrate interactions of phenylalanyl-tRNA synthetase from E.coli with tRNA. FEBS Lett. 232: 107-110.
32. Tuzikov F., Zinoviev V., Vavilin V., Malygin E. 1988b. Small-angle X-ray scattering study of enzyme-substrate interaction in solution. Stud. Biophys. 125: 169-172.
33. Tuzikov F., Zinoviev V., Vavilin V., Malygin E. 1996. Application of the small-angle X-ray scattering technique for the study of two-step equilibrium enzyme-substrate interactions. Biopolymers 38: 131-139.
34. Van Berkel P., Geerts M., van Veen H., Mericskay M., de Boier H., Nuijens J. 1997. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 328: 145-151.
35. Van Berkel P., van Veen H., Geerts M., de Boer H., Nuijens J. 1996. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants. Biochem. J. 319: 117-122.
36. Watanabe T., Nagura H., Watanabe K., Brown W., 1984. The bindingofhuman milk lactoferrin to immunoglobulin A. FEBS Lett. 168: 203-207.
37. Yudelevich IG, Cherevko AS, Engelsht VS, Pikalov VV, Tagiltsevand AP, Zheenbajev ZhZh. 1984. A two-jet plasmatron for the spectrochemical analysis of geological samples. Spectrochim. Acta 139B: 777-785.
38. Zimecki M., Mazurier J., Spik G., Kapp J. 1995. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86: 122-127.